Development of personalized EX vivo predictive technology for rapidly matching patient tumors with chemotherapy regimens before treatment
Ended Project Grant Awarded Last action
- Award ID
- R43CA254493
- Recipient
-
Cerflux Inc. UEI RJKTP1C2LNJ8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $405,148
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Funding
-
- $353,148.00 Federal
- $52,000.00 Non-federal
- Place of performance
- Alabama, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $52,000 | $0 | |
| Amendment | $52,000 | $52,000 | |
| Original award | $249,148 | $0 |
Quick answers
Who received award R43CA254493?
R43CA254493 was awarded to Cerflux Inc. by National Cancer Institute (National Institutes of Health) on September 10, 2020.
How much is award R43CA254493 worth?
$405,148 has been obligated on R43CA254493: $353,148 in federal funding and $52,000 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award